1. Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine

   • J. Remon
   • F. Tabbò
   • S. Novello

   Review Article 18 January 2020 Pages: 1425 - 1429

2. Genomic profiling in oncology clinical practice

   • N. Rodríguez
   • D. Viñal
   • G. Domínguez

   Review Article 24 January 2020 Pages: 1430 - 1439

3. Precision medicine in Ewing sarcoma: a translational point of view

   • P. Gargallo
   • A. Juan
   • A. Cañete

   Review Article 05 February 2020 Pages: 1440 - 1454

   

4. Treatment patterns for metastatic colorectal cancer in Spain

   • E. Aranda
   • E. Polo
   • A. Antón

   Research Article Open access 23 January 2020 Pages: 1455 - 1462

   

5. Gm6377 suppressed SP 2/0 xenograft tumor by down-regulating Myc transcription

   • B. Zhai
   • C. Hou
   • R. Wang

   Research Article 16 January 2020 Pages: 1463 - 1471

   

6. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome

   • S. Kashyap
   • J. Jha
   • N. Pushker

   Research Article 02 March 2020 Pages: 1472 - 1480

   

7. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer

   • A. Iglesias-Santamaría

   Research Article 09 January 2020 Pages: 1481 - 1490

   

8. Regorafenib and ginsenoside combination therapy: inhibition of HepG2 cell growth through modulating survivin and caspase-3 gene expression

   • B. Wang
   • F. Wang
   • X. Bu

   Research Article 22 January 2020 Pages: 1491 - 1498

   

9. A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer

   • X. Chen-Zhao
   • O. Hernando
   • C. Rubio

   Research Article 23 January 2020 Pages: 1499 - 1505

   

10. RNF213 suppresses carcinogenesis in glioblastoma by affecting MAPK/JNK signaling pathway

    • X. Wang
    • M. Ye
    • X. Zhu

    Research Article 17 January 2020 Pages: 1506 - 1516

    

11. Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma

    • J.-F. M. José
    • M. Jose
    • G. Vicente

    Research Article 11 February 2020 Pages: 1517 - 1523

    

12. The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma

    • A. Cox
    • Y. Tolkach
    • J. Ellinger

    Research Article Open access 21 January 2020 Pages: 1524 - 1531

    

13. Hypofractionated volumetric modulated arc therapy (VMAT) for fragile patients with oesophageal cancer

    • Letizia Deantonio
    • Simona Cima
    • Mariacarla Valli

    Research Article 22 January 2020 Pages: 1532 - 1538

    

14. Cyclooxygenase-2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma

    • Y. Elborai
    • A. Elgammal
    • L. M. Shalaby

    Research Article 22 January 2020 Pages: 1539 - 1547

    

15. Prognostic and predictive values of CXCL10 in colorectal cancer

    • J. Chen
    • Q.-L. Chen
    • S.-B. Su

    Research Article 03 February 2020 Pages: 1548 - 1564

    

16. A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus

    • S. Vázquez Estévez
    • U. Anido
    • L. M. Anton Aparicio

    Research Article 15 February 2020 Pages: 1565 - 1579

    

17. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis

    • Y. Shuai
    • C. Li
    • X. Zhou

    Research Article 14 February 2020 Pages: 1580 - 1590

    

18. DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations

    • Y. Gao
    • G. J. Khan
    • S. Yuan

    Research Article 13 February 2020 Pages: 1591 - 1602

    

19. Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

    • A. Bonaventura
    • F. Grossi
    • F. Montecucco

    Research Article 11 February 2020 Pages: 1603 - 1610

    

20. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution

    • J. A. Avilés-Izquierdo
    • L. M. Nieto-Benito
    • E. Mercader-Cidoncha

    Research Article 17 February 2020 Pages: 1611 - 1618

    

21. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells

    • S. Yousefnia
    • D. Naseri
    • K. Ghaedi

    Research Article 13 February 2020 Pages: 1619 - 1634

    

22. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study

    • J. M. Nieto-Guerrero Gómez
    • G. P. Silva Vega
    • J. L. López Guerra

    Research Article 18 February 2020 Pages: 1635 - 1644

    

23. Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population-based study

    • O. Abdel-Rahman

    Brief Research Article 14 January 2020 Pages: 1645 - 1650

    

24. Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials

    • O. Abdel-Rahman
    • S. Ghosh
    • J. Walker

    Brief Research Article 01 February 2020 Pages: 1651 - 1656

    

25. Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis

    • Sebastiano Buti
    • Fausto Petrelli
    • Melissa Bersanelli

    Brief Research Article 19 January 2020 Pages: 1657 - 1663

    

26. Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk

    • G. Roviello
    • D. Villari
    • R. Roudi

    Correspondence 20 April 2020 Pages: 1664 - 1665